Skip to main content
Lunit Inc. logo

Lunit Inc. — Investor Relations & Filings

Ticker · 328130 ISIN · KR7328130000 KO Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Filings indexed 307 across all filing types
Latest filing 2024-08-27 Major Shareholding Noti…
Country KR South Korea
Listing KO 328130

About Lunit Inc.

https://www.lunit.io/

Lunit Inc. develops and provides advanced medical artificial intelligence (AI) software focused on cancer diagnostics and therapeutics. The company's core offering is a platform-based AI ecosystem designed to analyze and interpret medical data, including radiological images and pathology slides. Its solutions, such as the Lunit INSIGHT suite for mammography and chest X-ray analysis, assist healthcare professionals in the early detection of cancer, enhancing diagnostic accuracy and workflow efficiency. In precision oncology, Lunit's AI technology supports biomarker discovery and treatment response prediction by analyzing tissue pathology. The company also collaborates with biopharmaceutical partners to accelerate oncology drug development and create AI-powered companion diagnostics. Lunit's platform integrates multimodal data to provide actionable insights across the cancer care continuum, from screening to treatment.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details a change in share ownership (a decrease of 400,000 shares) by Guardant Health, Inc. in the company Lunit. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) as it tracks significant changes in ownership thresholds.
2024-08-27 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed by an executive (Kenneth Gabriel Nesmith) of Lunit Inc. This is a standard regulatory filing in South Korea (DART system) used to report insider trading or changes in share ownership by company directors/executives. Based on the provided definitions, this falls under 'Director's Dealing' (DIRS).
2024-08-14 Korean
반기보고서 (2024.06)
Interim / Quarterly Report Classification · 1% confidence The document is a '반기보고서' (Semi-Annual Report) for Lunit Inc., covering the period from January 1, 2024, to June 30, 2024. It contains detailed company information, business operations, financial data, and management discussions, which are characteristic of an interim financial report. It is not an announcement of a report, but the report itself. H1 2024
2024-08-13 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 1% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) submitted to the Financial Services Commission/Korea Exchange. It details the issuance of stock options to employees and executives, including the number of shares, exercise price, and vesting conditions. This type of corporate action regarding capital structure and equity-based compensation is classified as a regulatory filing related to share issuance/capital changes.
2024-08-12 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 1% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) and specifically a '정정신고' (Amendment Report). It details changes to previously granted stock options, including adjustments to the number of shares and the list of recipients due to employee departures. This type of filing is a standard regulatory disclosure regarding capital structure and executive/employee compensation instruments, which falls under the 'Regulatory Filings' category as it does not fit into specific categories like 'Director's Dealing' (which is for personal trades) or 'Remuneration Information' (which is typically for annual proxy statements).
2024-08-12 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 1% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) and is specifically an amendment ('정정신고') to a previous filing. It details changes to the number of stock options granted to employees and directors due to resignations. This type of disclosure regarding equity compensation and capital structure changes falls under the category of Regulatory Filings (RNS) as it is a specific corporate disclosure required by the Korea Exchange/Financial Supervisory Service that does not fit into the other specialized categories like DIRS (which is for individual director trades) or SHA (which is for general share issuance).
2024-08-12 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.